• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

创新方法减少意外怀孕和改善使用阿片类药物的女性获得避孕措施的机会。

Innovative approaches to reduce unintended pregnancy and improve access to contraception among women who use opioids.

机构信息

Vermont Center on Behavior and Health, University of Vermont, United States of America; Department of Psychological Sciences, University of Vermont, United States of America; Department of Psychiatry, University of Vermont, United States of America.

Vermont Center on Behavior and Health, University of Vermont, United States of America; Department of Psychological Sciences, University of Vermont, United States of America.

出版信息

Prev Med. 2019 Nov;128:105794. doi: 10.1016/j.ypmed.2019.105794. Epub 2019 Aug 6.

DOI:10.1016/j.ypmed.2019.105794
PMID:31398412
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6879827/
Abstract

Dramatic increases in the rate of opioid use disorder (OUD) during pregnancy have been paralleled by substantial increases in the number of neonates diagnosed with neonatal abstinence syndrome (NAS). Women with OUD have reliably reported high rates of unintended pregnancy and a number of studies also indicate they desire easier access to contraception. Recent statements from the Centers for Disease Control and Prevention and the American Academy of Pediatrics/American College of Obstetricians and Gynecologists have drawn increased attention to efforts to prevent unintended pregnancy and improve access to contraception among women with OUD. We briefly review a number of innovative clinical approaches in these areas, including efforts to integrate family planning services into substance use disorder (SUD) treatment and other settings that serve people with OUD and interventions that aim to make family planning a higher priority among women with OUD. Results suggest many of these approaches have led to increases in contraceptive use and may aid in efforts to reduce unintended pregnancy and improve access to contraception among women with OUD now and in the future.

摘要

孕期阿片类药物使用障碍(OUD)发生率的急剧上升,与新生儿戒断综合征(NAS)的诊断数量的大幅增加是同步的。患有 OUD 的女性可靠地报告了高比例的意外怀孕,而且一些研究也表明,她们希望更容易获得避孕措施。最近疾病控制与预防中心和美国儿科学会/美国妇产科医师学会的声明,引起了人们对预防意外怀孕和改善 OUD 女性获得避孕措施的关注。我们简要回顾了这些领域的一些创新临床方法,包括将计划生育服务纳入物质使用障碍(SUD)治疗和其他服务 OUD 患者的环境,以及旨在使计划生育成为 OUD 女性更高优先级的干预措施。结果表明,这些方法中的许多方法已经导致避孕措施的使用增加,并可能有助于减少 OUD 女性的意外怀孕和改善她们获得避孕措施的机会。

相似文献

1
Innovative approaches to reduce unintended pregnancy and improve access to contraception among women who use opioids.创新方法减少意外怀孕和改善使用阿片类药物的女性获得避孕措施的机会。
Prev Med. 2019 Nov;128:105794. doi: 10.1016/j.ypmed.2019.105794. Epub 2019 Aug 6.
2
Factors Affecting Contraception Access and Use in Patients With Opioid Use Disorder.影响阿片类药物使用障碍患者避孕措施获得和使用的因素。
J Clin Pharmacol. 2020 Dec;60 Suppl 2:S63-S73. doi: 10.1002/jcph.1772.
3
Long-acting reversible contraceptives (LARCs) as harm reduction: a qualitative study exploring views of women with histories of opioid misuse.长效可逆避孕措施(LARCs)作为减少伤害的方法:一项探索有阿片类药物滥用史的女性观点的定性研究。
Harm Reduct J. 2021 Aug 4;18(1):83. doi: 10.1186/s12954-021-00532-1.
4
Contraception Practices Among Women on Opioid Agonist Therapy.阿片类激动剂治疗女性的避孕措施。
J Obstet Gynaecol Can. 2021 Feb;43(2):204-210. doi: 10.1016/j.jogc.2020.06.027. Epub 2020 Aug 4.
5
Increasing access to family planning services among women receiving medications for opioid use disorder: A pilot randomized trial examining a peer-led navigation intervention.增加接受阿片类药物使用障碍治疗的女性获得计划生育服务的机会:一项试点随机试验,研究了一种由同伴主导的导航干预措施。
J Subst Abuse Treat. 2021 Jul;126:108318. doi: 10.1016/j.jsat.2021.108318. Epub 2021 Feb 4.
6
Family Planning American Style Redux: Unintended Pregnancy Improves, Barriers Remain.美国式计划生育再现:意外怀孕情况有所改善,但障碍依然存在。
Obstet Gynecol Clin North Am. 2017 Mar;44(1):41-56. doi: 10.1016/j.ogc.2016.11.001.
7
Expanding Contraception Access for Women With Opioid-Use Disorder: A Qualitative Study of Opportunities and Challenges.扩大阿片类药物使用障碍女性的避孕途径:机遇与挑战的定性研究
Am J Health Promot. 2020 Nov;34(8):909-918. doi: 10.1177/0890117120927327. Epub 2020 May 29.
8
A Review of Unintended Pregnancy in Opioid-Using Women: Implications for Nursing.阿片类药物使用者意外怀孕的综述:对护理的启示。
J Addict Nurs. 2021;32(2):107-114. doi: 10.1097/JAN.0000000000000396.
9
Averting neonatal abstinence syndrome and treating addiction among rural, opioid-using young women.预防新生儿戒断综合征和治疗农村地区阿片类药物使用的年轻女性的成瘾问题。
Am J Addict. 2022 Sep;31(5):441-446. doi: 10.1111/ajad.13299. Epub 2022 May 9.
10
Performance Measures for Contraceptive Care: A New Tool to Enhance Access to Contraception.避孕护理的绩效指标:增强避孕服务可及性的新工具。
Obstet Gynecol. 2017 Nov;130(5):1121-1125. doi: 10.1097/AOG.0000000000002314.

引用本文的文献

1
Championing reproductive and perinatal health with the recovery community: improving access to healthcare and health promotion resources to support recovery.与康复社区共同倡导生殖与围产期健康:改善医疗保健和健康促进资源的可及性,以支持康复。
Front Public Health. 2025 May 14;13:1529169. doi: 10.3389/fpubh.2025.1529169. eCollection 2025.
2
Exploring the harm reduction paradigm: the role of Board-Certified Psychiatric Pharmacists.探索减少伤害范式:执业精神科药剂师的作用。
Ment Health Clin. 2024 Aug 2;14(4):253-266. doi: 10.9740/mhc.2024.08.253. eCollection 2024 Aug.
3
Contraception use among individuals with substance use disorder increases tenfold with patient-centered, mobile services: a quasi-experimental study.以患者为中心的移动服务使物质使用障碍者的避孕措施使用率增加十倍:一项准实验研究。
Harm Reduct J. 2023 Mar 6;20(1):28. doi: 10.1186/s12954-023-00760-7.
4
Client Characteristics Associated with Desire for Additional Services at Syringe Exchange Programs.与注射器交换项目中对额外服务的需求相关的客户特征。
J Subst Use. 2022;27(6):604-610. doi: 10.1080/14659891.2021.1967486. Epub 2021 Aug 17.
5
Contraception claims by medication for opioid use disorder prescription status among insured women with opioid use disorder, United States, 2018.医保覆盖人群中,患有阿片类药物使用障碍的女性,其处方药物的避孕功效声明,美国,2018 年。
Contraception. 2023 Jan;117:67-72. doi: 10.1016/j.contraception.2022.09.129. Epub 2022 Oct 12.
6
Ethical Issues in Providing and Promoting Contraception to Women with Opioid Use Disorder.为患有阿片类药物使用障碍的女性提供和推广避孕措施的伦理问题。
J Clin Ethics. 2022 Summer;33(2):112-123.
7
Association of Prepregnancy Substance Use and Substance Use Disorders with Pregnancy Timing and Intention.孕前物质使用及物质使用障碍与怀孕时机和意愿的关联
J Womens Health (Larchmt). 2022 Nov;31(11):1630-1638. doi: 10.1089/jwh.2021.0483. Epub 2022 Mar 23.
8
Miscarriage and Abortion Among Women Attending Harm Reduction Services in Philadelphia: Correlations With Individual, Interpersonal, and Structural Factors.费城接受减少伤害服务的妇女中的流产和堕胎:与个体、人际和结构因素的相关性。
Subst Use Misuse. 2022;57(6):999-1006. doi: 10.1080/10826084.2022.2046100. Epub 2022 Mar 11.
9
Contraception Policies in U.S. Jails, Prisons, and Juvenile Detention Systems: A National Survey.美国监狱、看守所和少年拘留系统中的避孕政策:全国性调查。
J Correct Health Care. 2021 Dec;27(4):226-231. doi: 10.1089/jchc.19.07.0060. Epub 2021 Aug 12.
10
Sex and female empowerment (SAFE): A randomized trial comparing sexual health interventions for women in treatment for opioid use disorder.性与女性赋权(SAFE):一项比较针对阿片类药物使用障碍女性患者性健康干预措施的随机试验。
Drug Alcohol Depend. 2021 Apr 1;221:108634. doi: 10.1016/j.drugalcdep.2021.108634. Epub 2021 Feb 17.

本文引用的文献

1
Understanding the Family Planning Needs of Female Participants in a Syringe Exchange Program: A Needs Assessment and Pilot Project.了解参与注射毒品者针具交换项目的女性参与者的计划生育需求:需求评估和试点项目。
J Addict Med. 2019 Sep/Oct;13(5):366-371. doi: 10.1097/ADM.0000000000000508.
2
Substance Use Treatment Patient and Provider Perspectives on Accessing Sexual and Reproductive Health Services: Barriers, Facilitators, and the Need for Integration of Care.物质使用治疗:患者和提供者对获得性健康和生殖健康服务的看法:障碍、促进因素以及整合护理的必要性。
Subst Use Misuse. 2020;55(1):95-107. doi: 10.1080/10826084.2019.1656255. Epub 2019 Aug 27.
3
Barriers to Reproductive Healthcare for Women With Opioid Use Disorder.患有阿片类物质使用障碍的女性在生殖健康护理方面面临的障碍。
J Perinat Neonatal Nurs. 2019 Apr/Jun;33(2):E3-E11. doi: 10.1097/JPN.0000000000000401.
4
Shared negative experiences of long-acting reversible contraception and their influence on contraceptive decision-making: a multi-methods study.长效可逆避孕措施的共同负面经历及其对避孕决策的影响:一项多方法研究。
Contraception. 2019 Apr;99(4):228-232. doi: 10.1016/j.contraception.2019.01.002. Epub 2019 Jan 24.
5
Does co-location of medication assisted treatment and prenatal care for women with opioid use disorder increase pregnancy planning, length of interpregnancy interval, and postpartum contraceptive uptake?美沙酮维持治疗与阿片类药物使用障碍孕妇产前护理共同实施能否增加妊娠计划、增加孕期间隔时间和产后避孕措施的采用?
J Subst Abuse Treat. 2019 Mar;98:73-77. doi: 10.1016/j.jsat.2018.12.001. Epub 2018 Dec 6.
6
Pregnancy Intention, Risk Perception, and Contraceptive Use in Pregnant Women Who Use Drugs.孕妇吸毒者的妊娠意向、风险认知和避孕措施使用情况。
J Addict Med. 2019 May/Jun;13(3):177-181. doi: 10.1097/ADM.0000000000000471.
7
Expanding Contraceptive Access for Women With Substance Use Disorders: Partnerships Between Public Health Departments and County Jails.扩大为患有物质使用障碍的女性提供避孕措施的机会:公共卫生部门与县监狱之间的合作关系。
J Public Health Manag Pract. 2019 May/Jun;25(3):229-237. doi: 10.1097/PHH.0000000000000850.
8
Opioid Use Disorder Documented at Delivery Hospitalization - United States, 1999-2014.分娩住院时记录的阿片类药物使用障碍 - 美国,1999-2014 年。
MMWR Morb Mortal Wkly Rep. 2018 Aug 10;67(31):845-849. doi: 10.15585/mmwr.mm6731a1.
9
Reproductive Health Knowledge, Attitudes, and Behaviors Among Women Enrolled in Medication-Assisted Treatment for Opioid Use Disorder.药物辅助治疗阿片类药物使用障碍女性的生殖健康知识、态度和行为。
J Womens Health (Larchmt). 2018 Oct;27(10):1215-1224. doi: 10.1089/jwh.2017.6564. Epub 2018 Jul 3.
10
The Pregnancy Recovery Center: A women-centered treatment program for pregnant and postpartum women with opioid use disorder.妊娠康复中心:一个以妇女为中心的治疗项目,针对患有阿片类药物使用障碍的孕妇和产后妇女。
Addict Behav. 2018 Nov;86:124-129. doi: 10.1016/j.addbeh.2018.05.016. Epub 2018 May 24.